UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045261
Receipt number R000051683
Scientific Title The prospective study about the relationship between blepharoptosis and motor ability / social activity -based on Patient-Reported Outcomes-
Date of disclosure of the study information 2021/09/01
Last modified on 2025/03/04 19:07:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The prospective study about the relationship between blepharoptosis and motor ability / social activity -based on Patient-Reported Outcomes-

Acronym

The prospective study about the relationship between blepharoptosis and motor ability / social activity -based on Patient-Reported Outcomes-

Scientific Title

The prospective study about the relationship between blepharoptosis and motor ability / social activity -based on Patient-Reported Outcomes-

Scientific Title:Acronym

The prospective study about the relationship between blepharoptosis and motor ability / social activity -based on Patient-Reported Outcomes-

Region

Japan


Condition

Condition

blepharoptosis

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate how the treatment of blepharoptosis will change the patient's motor ability and social activity.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Based on the date of the severity of ptosis, walking speed and other motor skills(pre-ope, post 6 months), we evaluate the preoperative and postoperative changes.

Key secondary outcomes

After translation of FACE-Q, which is one of PRO, we make patients to answer it pre-operation and post 6 month and two weeks later and evaluate the preoperative and postoperative changes.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients aged 20 years or older who undergo blepharoptosis surgery and who can decide to participate in the study on their own initiative. The motor ability is evaluated at the age of 60 and over.

Key exclusion criteria

Those who cannot fill out the questionnaire by themselves, need a substitute, and do not speak Japanese as their mother tongue. In addition, those who have motor disorders due to musculoskeletal system or nervous system diseases, and those who have difficulty in implementing the evaluation items for other reasons are excluded from the motor ability evaluation.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Noriko
Middle name
Last name Uemura

Organization

Institute of Science Tokyo

Division name

Plastic and Reconstruction Surgery

Zip code

113-8510

Address

1-5-45,Yushima,Bunkyo-ku,Tokyo, JAPAN

TEL

03-5803-5923

Email

noriplas@tmd.ac.jp


Public contact

Name of contact person

1st name Sayuri
Middle name
Last name Kato

Organization

Institute of Science Tokyo

Division name

Plastic and Reconstruction Surgery

Zip code

113-8510

Address

1-5-45,Yushima,Bunkyo-ku,Tokyo, JAPAN

TEL

03-5803-5923

Homepage URL


Email

sayu.plas@tmd.ac.jp


Sponsor or person

Institute

Plastic and Reconstructive surgery, Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)

Takatsuki Orthopaedic Hospital


IRB Contact (For public release)

Organization

Institute of Science Tokyo

Address

1-5-45,Yushima,Bunkyo-ku,Tokyo, JAPAN

Tel

03-3813-6111

Email

syomu1.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

65

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 08 Month 04 Day

Date of IRB

2021 Year 12 Month 23 Day

Anticipated trial start date

2021 Year 09 Month 01 Day

Last follow-up date

2025 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observe the patient's eyelid findings, motor ability, and PRO results before and after surgery.


Management information

Registered date

2021 Year 08 Month 25 Day

Last modified on

2025 Year 03 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051683